Survival and Quality of Life After Liver Transplantation in Patients Aged 65 and Over
NCT ID: NCT04754503
Last Updated: 2023-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
125 participants
OBSERVATIONAL
2021-04-09
2025-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Adult-to-Adult Living Donor Liver Transplantation Study
NCT00096733
Long-term Mortality Post Liver Transplantation in the Era of Modern Immunosuppression.
NCT06636409
Left Lobe Versus Right Lobe in Adult Living Donor Liver Transplantation in Borderline GRWR
NCT06542913
Data Collection Study From Donors and Recipients to Optimize Donor-recipient Matching in Liver Transplantation
NCT03371264
INTERNATIONAL SURVEY ON COMPLEXITY IN LIVER TRANSPLANTATION
NCT04348721
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Included patients will receive a standardized geriatric assessment in addition to the usual assessment for a liver transplant.
The geriatric assessment will be carried out and conducted as follows: geriatric scores and quality of life questionnaires. Two geriatricians will perform the physical examination and blindly estimate each other's probability of survival at 90 days using a Likert scale.
Geriatricians will be blinded to hepatic data (reasons for transplantation). The consultation as well as the completion of the questionnaire will be carried out during the pre-transplantation assessment.
Survival and quality of life will be assessed at 3 and 12 months post-transplantaion.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having expressed non-oppostion to his participation in study and documented in his medical file
* With social coverage
Exclusion Criteria
* Patient already included in another study
* Patient under guardianship or curatorship
* Expressing his opposition to participate in the study
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gérond'if
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Duron Emmanuelle, MD PhD
Role: STUDY_CHAIR
Geriatric Department, Paul Brousse Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Geriatric Department, Paul Brousse Hospital
Villejuif, Île-de-France Region, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-A03063-36
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.